Effect of Type 1 Diabetes on Sleep Fragmentation (DIAPASOM5)

Grenoble Alpes University Hospital Center (CHU)

Status: Unknown

Conditions: Type 1 Diabetes

Treatments: Other: Cross-sectional observational study

Study type: Observational

Funder types: Other

Identifiers

NCT04601519

38RC18.271

2018-A02474-51 (Other Identifier)

Details and patient eligibility

About

The main objective of this study is the objective evaluation of disease related sleep fragmentation in subjects with type 1 diabetes.

Full description

The influence of sleep duration and sleep schedules (social jetlag) on glycemic control in type 1 diabetes has been shown in several previous studies, including by the investigators of this study.

Following these publications, patients have expressed the opinion via social networks that type 1 diabetes disease is itself a factor that alters the quality of sleep. Indeed, it appears that the cross-sectional studies published to date have focused on the association between the subjects' sleep habits and the balance of their diabetes, without having questioned the role of the pathology on sleep quality.

The main objective of this study is the objective evaluation of disease related sleep fragmentation in subjects with type 1 diabetes.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Self-reported type 1 diabetes
• Male or female
• Self-reported age > 18 years old
• Subject user of a freestyle capillary meter

Exclusion criteria

• Opposition to Use of Data for Teaching and Research Purposes
• Other type of diabetes
• Self-reported age under 18 years of age
• Subject non-user of a freestyle capillary meter

Trial design

100 participants in 1 patient group

Patients-type 1 diabetes

Description:

Participants are recruited by e-mail, among the users of the libreview platform (Abbott), who are followed up for type 1 diabetes at the CHU Grenoble Alpes (France), to participate in an anonymous online questionnaire and to allow their glycemic data extracted from the libreview platform to be used for the research.

Treatment:

Other: Cross-sectional observational study